Dr. Patrick W. Lam, MD
Cardiology (Cardiovascular Disease Physician)
- Medicare participating
At a glance
- Years since graduation
- 36
- In the NPI registry since
- 2005
- Medicare patients seen, 2024
- 620
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2005Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Cardiovascular Disease Physician primary
NY license 241137
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mount Sinai Hospital New York, NY
- Mount Sinai West New York, NY
- Mount Sinai Beth Israel New York, NY
Medical groups
- Icahn School of Medicine at Mount Sinai (2,843 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 620
- Services billed
- 2,640
- Patients’ average age
- 79
| Service | Times | Patients |
|---|---|---|
| Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and tec | 525 | 114 |
| Evaluation of cardiac rhythm monitor system, remote up to 30 days | 413 | 86 |
| Established patient office or other outpatient visit, 30-39 minutes | 386 | 195 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 245 | 148 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 236 | 103 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 172 | 75 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 142 | 30 |
| Programming of dual lead pacemaker system | 141 | 96 |
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 90 | 54 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 85 | 34 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Eliquis (apixaban) Other prescribers in New York, NY | 250 |
| Metoprolol Succinate Other prescribers in New York, NY | 244 |
| Xarelto (rivaroxaban) Other prescribers in New York, NY | 136 |
| Amiodarone Hcl Other prescribers in New York, NY | 115 |
| Flecainide Acetate Other prescribers in New York, NY | 90 |
| Atorvastatin Calcium Other prescribers in New York, NY | 62 |
| Metoprolol Tartrate Other prescribers in New York, NY | 62 |
| Dofetilide | 58 |
| Amlodipine Besylate Other prescribers in New York, NY | 56 |
| Multaq (dronedarone hcl) Other prescribers in New York, NY | 47 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 10 companies reported 57 payments worth $2,017 in total to this clinician.
| Boston Scientific Corporation | $1,286 |
|---|---|
| Abbott Laboratories | $229 |
| Novartis Pharmaceuticals Corporation | $187 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $158 |
| E.r. Squibb & Sons, L.l.c. | $31.02 |
| Medtronic, Inc. | $29.21 |
| Merck Sharp & Dohme LLC | $27.53 |
| Heartflow, Inc. | $24.02 |
| Food and Beverage | $2,017 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.